Aspire Private Capital, LLC Bio Rad Laboratories, Inc. Transaction History

Aspire Private Capital, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 30, 2023	SELL	$418.69 - $503.0 $418 - $503	-1 Reduced 11.11%	8 $3,000
Q1 2023 May 03, 2023	SELL	$418.69 - $503.0 $418 - $503	-1 Reduced 11.11%	8 $3,000
Q4 2022 May 30, 2023	BUY	$351.71 - $456.01 $351 - $456	1 Added 12.5%	9 $3,000
Q4 2021 Feb 14, 2022	SELL	$708.84 - $794.68 $708 - $794	-1 Reduced 10.0%	9 $7,000
Q2 2021 Aug 09, 2021	SELL	$576.64 - $649.04 $12,686 - $14,278	-22 Reduced 68.75%	10 $6,000
Q1 2021 May 26, 2021	BUY	$547.01 - $662.35 $16,410 - $19,870	30 Added 1500.0%	32 $18,000
Q3 2020 Nov 13, 2020	SELL	$454.43 - $535.6 $14,087 - $16,603	-31 Reduced 93.94%	2 $1,000
Q2 2020 Aug 13, 2020	BUY	$334.87 - $493.06 $11,050 - $16,270	33 New	33 $15,000

457

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.38B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Aspire Private Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Aspire Private Capital, LLC with notifications on news.